PHAR (Pharming Group) Total Liabilities: $220.4 Mil (As of Mar. 2026)


PHAR Pharming Group PHAR
76 GF Score
Price $13.89
GF Value $14.36
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Pharming Group Total Liabilities?

Pharming Group PHAR +3.73% 76 Total Liabilities is $220.4 Mil as of Mar. 2026. GuruFocus rates PHAR with a GF Score™ of 76/100 and a GF Value™ of $14.36 (Fairly Valued). The stock has 1 warning sign investors should review.

Pharming Group's Total Liabilities for the quarter that ended in Mar. 2026 was $220.4 Mil.

Pharming Group's quarterly Total Liabilities increased from Sep. 2025 ($209.14 Mil) to Dec. 2025 ($222.86 Mil) but then declined from Dec. 2025 ($222.86 Mil) to Mar. 2026 ($220.41 Mil).

Pharming Group's annual Total Liabilities declined from Dec. 2023 ($244.07 Mil) to Dec. 2024 ($178.92 Mil) but then increased from Dec. 2024 ($178.92 Mil) to Dec. 2025 ($222.86 Mil).

Pharming Group Total Liabilities Historical Data

* Premium members only.

The historical data trend for Pharming Group's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharming Group Total Liabilities Chart

Pharming Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 204.40 221.16 244.07 178.92 222.86

Pharming Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 187.89 206.71 209.14 222.86 220.41
PHAR
76GF Score
Pharming Group PHAR
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharming Group Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Pharming Group's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=115.791+(107.07+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=222.9

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=499.963-277.102
=222.9

Pharming Group's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=112.346+(108.06+-0.0010000000000048
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=220.4

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=489.365-268.96
=220.4

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $220.4 Mil mean?
Pharming Group (PHAR) has a Total Liabilities of $220.4 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Pharming Group and its competitors.
Is Pharming Group's Total Liabilities too high?
Pharming Group's current Total Liabilities is $220.4 Mil. Overall, Pharming Group has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pharming Group's Total Liabilities compare to VRTX and REGN?
Pharming Group's Total Liabilities of $220.4 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Pharming Group and its competitors. Pharming Group's current Total Liabilities is $220.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharming Group stock overvalued right now?
Based on GuruFocus' analysis, Pharming Group (PHAR) is currently considered Fairly Valued. The stock's GF Value™ is $14.36, compared to a current price of $13.89 — trading 3.3% below its estimated fair value. The current Total Liabilities is $220.4 Mil. Pharming Group's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Pharming Group (PHAR), the current Total Liabilities is $220.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharming Group (PHAR) Overvalued in 2026?

Based on GuruFocus' analysis, Pharming Group stock appears to be undervalued. The current stock price of $13.89 is trading 3.3% below its estimated GF Value™ of $14.36. GuruFocus considers Pharming Group to be Fairly Valued.

Key valuation signals for PHAR:

  • Total Liabilities: $220.4 Mil
  • GF Value™: $14.36 vs. price of $13.89 (3.3% below fair value)
  • GF Score™: 76/100 with 1 warning sign

No single metric tells the full story. See the PHAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharming Group Business Description

Address Darwinweg 24, Leiden, ZH, NLD, 2333 CR
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
76GF Score

Get the complete analysis for PHAR

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.89
Price
$14.36
GF Value